- Home
- GWH vs CING Comparison
GWH vs CING Comparison
Compare GWH & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GWH
- CING
- Stock Information
- Founded
- GWH 2011
- CING 2012
- Country
- GWH United States
- CING United States
- Employees
- GWH N/A
- CING N/A
- Industry
- GWH Industrial Machinery/Components
- CING Biotechnology: Pharmaceutical Preparations
- Sector
- GWH Miscellaneous
- CING Health Care
- Exchange
- GWH Nasdaq
- CING Nasdaq
- Market Cap
- GWH 25.3M
- CING 26.7M
- IPO Year
- GWH N/A
- CING 2021
- Fundamental
- Price
- GWH $1.58
- CING $4.19
- Analyst Decision
- GWH Hold
- CING Strong Buy
- Analyst Count
- GWH 4
- CING 4
- Target Price
- GWH $2.67
- CING $31.00
- AVG Volume (30 Days)
- GWH 210.3K
- CING 163.1K
- Earning Date
- GWH 08-14-2025
- CING 08-19-2025
- Dividend Yield
- GWH N/A
- CING N/A
- EPS Growth
- GWH N/A
- CING N/A
- EPS
- GWH N/A
- CING N/A
- Revenue
- GWH $6,166,000.00
- CING N/A
- Revenue This Year
- GWH $124.62
- CING N/A
- Revenue Next Year
- GWH $245.00
- CING N/A
- P/E Ratio
- GWH N/A
- CING N/A
- Revenue Growth
- GWH N/A
- CING N/A
- 52 Week Low
- GWH $0.76
- CING $3.02
- 52 Week High
- GWH $10.12
- CING $12.40
- Technical
- Relative Strength Index (RSI)
- GWH 43.68
- CING 45.55
- Support Level
- GWH $1.36
- CING $3.71
- Resistance Level
- GWH $1.69
- CING $4.31
- Average True Range (ATR)
- GWH 0.17
- CING 0.39
- MACD
- GWH -0.03
- CING -0.03
- Stochastic Oscillator
- GWH 30.44
- CING 36.67
About GWH ESS Tech Inc.
ESS Tech Inc is a long-duration energy storage company specializing in iron flow battery technology. The company design and produce long-duration batteries predominantly using earth-abundant materials.
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.